期刊文献+

胃转流术对糖尿病大鼠降糖作用的实验研究 被引量:1

Effects of gastric bypass on blood glucose in rats with diabetes mellitus
暂未订购
导出
摘要 目的研究胃肠转流手术(GBP)对非肥胖型糖尿病大鼠的降糖效果与术后进食量、体重的关系。方法健康雄性wistar大鼠,腹腔注射链脲佐菌素(STZ)建立糖尿病模型。随机分成3组,O组:GBP手术组;F组:饮食控制组;C组:空白对照组。观察各组大鼠体重、平均进食量,分别测定术前、术后1、2、3、4、8周空腹及灌服葡萄糖30min后血糖水平。结果 O组GBP后4周,空腹和灌服葡萄糖后血糖分别由(20.8±4.9)、(30.2±3.1)mmol/L下降到(11.6±2.9)、(16.6±3.1)mmol/L(P<0.01)。O组体重改变无统计学意义。F组控制平均进食量约为O组的1/3并致体重显著下降,血糖下降没有O组明显。结论胃转流术对糖尿病大鼠具有明显治疗作用,其降糖作用与术后体重下降及进食量无关。 Objective To investigate the effects of gastric bypass (GBP) on hypoglycemic activity,food-intake after GBP and body weight in rats with non-obesity diabetes mellitus.Methods The animal models with diabetes mellitus were established in 24 male Wistar rats by intraperitoneal injection with STZ,then the rats were randomly divided into 3 groups:group O (GBP),group F (food restriction) and group C (blank controls).The blood glucose concentrations were measured respectively at fasting and postprandial condition before and on the 1st,2nd,3rd,4th and 8th week after GBP for all the rats,and the rats' body weight and average food-intake were detected simultaneously.Results At the 4th week after GBP,the fasting and postprandial blood glucose levels in group O were significantly decreased from (20.8±4.9),(30.2±3.1) mmol/L to (11.6±2.9),(16.6±3.1) mmol/L,respectively (P0.01).However there was no significant difference in the rats’ weight changes in group O.The average food-intake in group F was about one-third of group O,furthermore,the rats’ body weight was decreased,but the decrease of body weight was not as obvious as that in group O.Conclusion GBP has obvious therapeutic effect on diabetic rats,and its hypoglycemic activity is not related with the decrease of body weight after CBP and food-intake.
出处 《河北医药》 CAS 2012年第14期2096-2098,共3页 Hebei Medical Journal
关键词 胃转流术 糖尿病 大鼠 血糖 gastric bypass diabetes rats blood glucose
  • 相关文献

参考文献7

  • 1Rubino F, Marescaux J. Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes : a new perspective for an olddisease. Ann Surg ,2004,239 : 1-11.
  • 2Mingrone G, DeGaetano A, Greco AV, et al. Reversibility of insulin resistance in obese diabetic patients : role of plasma lipids. Diabetologia, 1997,40:599-605.
  • 3Scott E, Frank L, Stanley K. Effects of obesity surgery on non-insulin-de- pendent diabetes mellitus. Arch Surg,2002,137 : 1109-1117.
  • 4Rubino F, Gagner M, Gentileschi P, et al. The early effect of the Roux-en- Y gastric bypass on hormones involved in body weight regulation and glu- cose metabolism. Ann Surg,2004,240 : 236 -242.
  • 5UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treat- ment and risk of comp ; ications in patients with type 2 diabetes ( UKPDS 33 ). Lancet, 1998,352:837-853.
  • 6Noya G, Cossu ML, Coppola M, et al. Biliopancreatic diversion preserving the stomach and pylorus in the treatment of hypercholesterolemia and dia- betes type 11 :Results in the first 10 cases. Obes Surg,1998, 8:67-72.
  • 7张新国,杨学军,徐红,韩承新,贾元利,武金虎,张冶.胃旁路手术治疗Ⅱ型糖尿病的体会[J].中华普通外科杂志,2005,20(9):599-599. 被引量:100

二级参考文献2

  • 1Sugerman HJ, Wolfe LG, Sica DA, et al. Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss. Ann Surg, 2003,237:751-756.
  • 2Smith SC,Goodman GN, Edwards CB. Roux-en-Y gastric bypass: a 7-year retrospective review of 3855 patients. Obes Surg,1995,5:314-318.

共引文献99

同被引文献7

  • 1Falkén Y,Hellstr(o)m PM,Holst JJ. Changes in glucose homeostasis after Roux-en-Y gastric bypass surgery for obesity at day three,two months,and one year after surgery:role of gut peptides[J].Journal of Clinical Endocrinology and Metabolism,2011,(01):2227-2235.
  • 2Salehi M,Prigeon RL,D'Alessio DA. Gastric bypass surgery enhances glucagon-like peptide 1 stimulated postprandial insulin secretion in humans[J].Diabetes,2011,(01):2308-2314.
  • 3Halimi S,Debaty I,Villaret L. New therapies for type 2 diabetes:what place for incretin-based agents and rimonabant compared to the previous ones[J].Revue De Medecine Interne,2008,(11):881-890.
  • 4Mentlein R. Mechanisms underlying the rapid degradation and elimination of the incretin hormones GLP-1 and GIP[J].Best Practice and Research:Clinical Endocrinology and Metabolism,2009,(01):443-452.
  • 5Mathes CM,Bueter M,Smith KR. Roux-en-Y gastric bypass in rats increases sucrose taste-related motivated behavior independent of pharmacological GLP-1-receptor modulation[J].American Journal of Physiology-Regulatory Integrative and Comparative Physiology,2012,(06):751-767.
  • 6Alam ML,Van der Schueren BJ,Ahren B. Gastric bypass surgery,but not caloric restriction,decreases dipeptidyl peptidase-4 activity in obese patients with type 2 diabetes[J].Diabetes,Obesity and Metabolism,2011,(04):378-381.
  • 7Hansen EN,Tamboli RA,Isbell JM. Role of the foregut in the early improvement in glucose tolerance and insulin sensitivity following Roux-en-Y gastric bypass surgery[J].American Journal of Physiology-Gastrointestinal and Liver Physiology,2011,(01):G795-G802.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部